Intranasal vaccination with a Chimeric Chlamydial Antigen BD584 confers protection against Chlamydia trachomatis genital tract infection
Open Access
- 14 July 2020
- journal article
- Published by Peertechz Publications Private Limited in Journal of Vaccines and Immunology
- Vol. 6 (1), 010-017
- https://doi.org/10.17352/jvi.000030
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Animal Models for Studying Female Genital Tract Infection with Chlamydia trachomatisInfection and Immunity, 2013
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialThe New England Journal of Medicine, 2012
- Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus ProteinsInfection and Immunity, 2012
- Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccinesProceedings of the National Academy of Sciences of the United States of America, 2011
- Vaccination againstChlamydiaGenital Infection Utilizing the MurineC. muridarumModelInfection and Immunity, 2011
- Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plagueVaccine, 2008
- Fc Receptor–Mediated Antibody Regulation of T Cell Immunity against Intracellular PathogensThe Journal of Infectious Diseases, 2003
- Fc receptor regulation of protective immunity against Chlamydia trachomatisImmunology, 2002
- PcrV Immunization Enhances Survival of Burned Pseudomonas aeruginosa -Infected MiceInfection and Immunity, 2001
- Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype ProductionScience, 1987